Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study

The cardiac myosin phenotype, an important determinant of myocardial contractility, is modified by chronic increases in hemodynamic load. To quantify the proportion of atrial alpha-myosin heavy chain in various types of left atrial overload and to assess the possible relation between this proportion and atrial size, 34 patients were studied, 4 with Wolff-Parkinson-White syndrome, 29 with various types of mitral valve dysfunction and 1 with an atrial septal defect. Four normal autopsy hearts were also studied. The proportion of alpha-myosin heavy chain among total (alpha plus beta) myosin heavy chains was determined in each atrial sample, using an enzyme-linked immunosorbent assay. The size of the left atrium was assessed by one- and two-dimensional echocardiography. Alpha-myosin heavy chain was the main isoform present in the normal atria (85.5 +/- 9% of total myosin heavy chains). Patients with pure tight mitral stenosis (n = 9), mitral stenosis plus mild regurgitation (n = 8) and severe mitral regurgitation (n = 8), who had a higher indexed left atrial transverse diameter than those with Wolff-Parkinson-White syndrome (33 +/- 6, 39 +/- 10 and 46 +/- 5 versus 19.5 +/- 2 mm/m2, p less than 0.01, p less than 0.001 and p less than 0.001, respectively), also demonstrated a much smaller percent of alpha-myosin heavy chain content (28 +/- 20, 23.5 +/- 13 and 12 +/- 10 versus 58 +/- 18%, p less than 0.01, p less than 0.01 and p less than 0.001, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Vanderheyden, W. Mullens, L. Delrue, M. Goethals, B. de Bruyne, W. Wijns, P. Geelen, S. Verstreken, F. Wellens, and J. Bartunek Myocardial Gene Expression in Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Responders Versus Nonresponders J. Am. Coll. Cardiol., January 15, 2008; 51(2): 129 - 136. [Abstract] [Full Text] [PDF]

				C. Rucker-Martin, F. Pecker, D. Godreau, and S. N Hatem Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro Cardiovasc Res, July 1, 2002; 55(1): 38 - 52. [Abstract] [Full Text] [PDF]

				B Swynghedauw and D Charlemagne What is wrong with positive inotropic drugs? Lessons from basic science and clinical trials Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D43 - D49. [Abstract] [PDF]

				C. Aime-Sempe, T. Folliguet, C. Rucker-Martin, M. Krajewska, S. Krajewski, M. Heimburger, M. Aubier, J.-J. Mercadier, J. C. Reed, and S. N. Hatem Myocardial cell death in fibrillating and dilated human right atria J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1577 - 1586. [Abstract] [Full Text] [PDF]

				C.P. Clifford and D.J.R. Nunez Human {beta}-myosin heavy chain mRNA prevalence is inversely related to the degree of methylation of regulatory elements Cardiovasc Res, June 1, 1998; 38(3): 736 - 743. [Abstract] [Full Text] [PDF]

				J.-J. Mercadier, K. Schwartz, S. Schiaffino, C. Wisnewsky, S. Ausoni, M. Heimburger, R. Marrash, R. Pariente, and M. Aubier Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation Am J Physiol Lung Cell Mol Physiol, April 1, 1998; 274(4): L527 - L534. [Abstract] [Full Text] [PDF]

				R. L Young, A. L Gundlach, and W. J Louis Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: an in situ hybridization histochemical study Cardiovasc Res, January 1, 1998; 37(1): 187 - 201. [Abstract] [Full Text] [PDF]

				R. J. Wiesner, H. Ehmke, J. Faulhaber, R. Zak, and J. C. Ruegg Dissociation of Left Ventricular Hypertrophy, ß-Myosin Heavy Chain Gene Expression, and Myosin Isoform Switch in Rats After Ascending Aortic Stenosis Circulation, March 4, 1997; 95(5): 1253 - 1259. [Abstract] [Full Text]

				G. de Simone, R. B. Devereux, M. J. Koren, G. A. Mensah, P. N. Casale, and J. H. Laragh Midwall Left Ventricular Mechanics : An Independent Predictor of Cardiovascular Risk in Arterial Hypertension Circulation, January 15, 1996; 93(2): 259 - 265. [Abstract] [Full Text]